Get started
Author

M. Shingarova

Observed names: Meiri S. Shingarova, Meiri Sh Shingarova, Meiri Sh. Shingarova, Meiri Shingarova
OpenAlex ID: A5113861675
Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study
2023 · Ekaterina Alexeeva, Meiri Shingarova, et al. · Frontiers in Medicine · 16
PDF
Effectiveness and Safety of Rituximab in Patients with Refractory Juvenile Idiopathic Arthritis: A Tertiary Center Experience
2026 · Ekaterina I. Alexeeva, Natalia M. Kondrateva, et al. · Pharmaceuticals
Clinical and laboratory manifestations and treatment of children with TNFRSF1A gene variants
2026 · Ekaterina I Alexeeva, Meiri Sh Shingarova, et al. · World Journal of Clinical Pediatrics
PDF
Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare
2026 · Ekaterina I. Alexeeva, Irina T. Tsulukiya, et al. · Pharmaceuticals
PDF
Op0166 Disease Activity in Children With Juvenile Idiopathic Arthritis After Simultaneous Pcv13 and Hib Vaccination: a Cohort Study
2021 · O. Lomakina, E. Alexeeva, et al. · Annals of the Rheumatic Diseases
Thu0506 Long-term Effectiveness and Safety of Canakinumab as a Second Biologic After Tocilizumab in Children With Early and Late Jia With Active Systemic Features
2020 · E. Alexeeva, E. Krekhova, et al. · Annals of the Rheumatic Diseases
PDF
Sat0492 Rapid Improvement and Achievement of Inactive Disease in Children With Systemic Juvenile Idiopathic Arthritis Under 4 Years of Age Depending on Disease Duration on Tocilizumab Treatment
2020 · E. Krekhova, E. Alexeeva, et al. · Annals of the Rheumatic Diseases
PDF
Fri0464 Genotyping and Phenotyping Patterns in Patients With Caps in Russian Federation
2020 · M. Shingarova, E. Alexeeva, et al. · Annals of the Rheumatic Diseases
PDF
Thu0502 Efficacy and Safety of Secukinumab Treatment in Juvenile Idiopathic Arthritis Patients
2020 · I. Kriulin, E. Alexeeva, et al. · Annals of the Rheumatic Diseases
Fri0458 Efficacy and Safety of Pcv13 Vaccination in Jia Patients With Systemic Manifestations on Tocilizumab and Canakinumab Treatment
2020 · D. Vankova, E. Alexeeva, et al. · Annals of the Rheumatic Diseases
PDF
Ab0971 Long-term Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From a Single-center Study
2020 · E. Alexeeva, E. Krekhova, et al. · Annals of the Rheumatic Diseases
PDF
Секреторная диарея как паранеопластический синдром при нейробластоме
2018 · Сагоян Гарик Барисович, M. Shingarova, et al. · CyberLeninK (CyberLeninka)
PDF
Works count: 12
Citation count: 16
H-index: 1
I10-index: 1
Year
Topic
Type